July 7, 2026 Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas Read more
May 18, 2023 New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100™) Diagnostic in Heart Failure Outcomes Read more
October 3, 2018 Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer Read more
October 3, 2018 Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit Read more
June 24, 2017 Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall ’25 Read more